Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
23149448
TITLE
Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder.
ABSTRACT
Major depressive disorder (MDD) is a common psychiatric illness characterized by low mood and loss of interest in pleasurable activities. Despite years of effort, recent genome-wide association studies (GWAS) have identified few susceptibility variants or genes that are robustly associated with MDD. Standard single-SNP (single nucleotide polymorphism)-based GWAS analysis typically has limited power to deal with the extensive heterogeneity and substantial polygenic contribution of individually weak genetic effects underlying the pathogenesis of MDD. Here, we report an alternative, gene-set-based association analysis of MDD in an effort to identify groups of biologically related genetic variants that are involved in the same molecular function or cellular processes and exhibit a significant level of aggregated association with MDD. In particular, we used a text-mining-based data analysis to prioritize candidate gene sets implicated in MDD and conducted a multi-locus association analysis to look for enriched signals of nominally associated MDD susceptibility loci within each of the gene sets. Our primary analysis is based on the meta-analysis of three large MDD GWAS data sets (total N=4346 cases and 4430 controls). After correction for multiple testing, we found that genes involved in glutamatergic synaptic neurotransmission were significantly associated with MDD (set-based association P=6.9 ? 10(-4)). This result is consistent with previous studies that support a role of the glutamatergic system in synaptic plasticity and MDD and support the potential utility of targeting glutamatergic neurotransmission in the treatment of MDD.
DATE PUBLISHED
2012
HISTORY
PUBSTATUS PUBSTATUSDATE
entrez 2012/11/15 06:00
pubmed 2012/11/15 06:00
medline 2013/05/02 06:00
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Lee PH Lee P H PH Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA, USA.
Perlis RH Perlis R H RH
Jung JY Jung J-Y JY
Byrne EM Byrne E M EM
Rueckert E Rueckert E E
Siburian R Siburian R R
Haddad S Haddad S S
Mayerfeld CE Mayerfeld C E CE
Heath AC Heath A C AC
Pergadia ML Pergadia M L ML
Madden PA Madden P A F PA
Boomsma DI Boomsma D I DI
Penninx BW Penninx B W BW
Sklar P Sklar P P
Martin NG Martin N G NG
Wray NR Wray N R NR
Purcell SM Purcell S M SM
Smoller JW Smoller J W JW
INVESTIGATORS
JOURNAL
VOLUME: 2
ISSUE:
TITLE: Translational psychiatry
ISOABBREVIATION: Transl Psychiatry
YEAR: 2012
MONTH:
DAY:
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 2158-3188
ISSNTYPE: Electronic
MEDLINE JOURNAL
MEDLINETA: Transl Psychiatry
COUNTRY: United States
ISSNLINKING: 2158-3188
NLMUNIQUEID: 101562664
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
Meta-Analysis
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
COMMENTS AND CORRECTIONS
REFTYPE REFSOURCE REFPMID NOTE
Cites Am J Hum Genet. 2007 Sep;81(3):559-75 17701901
Cites Brain Res. 2007 Jun 4;1152:215-27 17434465
Cites Biol Psychiatry. 2007 Dec 1;62(11):1310-6 17574216
Cites Hum Hered. 2008;65(3):129-41 17934316
Cites Curr Psychiatry Rep. 2007 Dec;9(6):467-74 18221626
Cites Nat Rev Drug Discov. 2008 May;7(5):426-37 18425072
Cites Neurochem Res. 2008 Nov;33(11):2342-9 18473166
Cites PLoS Genet. 2008 Oct;4(10):e1000214 18846210
Cites Hum Mol Genet. 2008 Oct 15;17(R2):R122-8 18852200
Cites Nature. 2008 Oct 16;455(7215):894-902 18923511
Cites Biol Psychiatry. 2009 Feb 15;65(4):289-95 18822408
Cites Am J Hum Genet. 2009 Feb;84(2):210-23 19200528
Cites Mol Psychiatry. 2009 Apr;14(4):359-75 19065144
Cites Nature. 2009 May 28;459(7246):528-33 19404256
Cites Nature. 2009 May 28;459(7246):569-73 19404257
Cites Pharmacol Ther. 2009 Aug;123(2):143-50 19397926
Cites PLoS Genet. 2009 Jun;5(6):e1000534 19557189
Cites Am J Hum Genet. 2009 Jul;85(1):13-24 19539887
Cites Nature. 2009 Aug 6;460(7256):748-52 19571811
Cites Am J Hum Genet. 2009 Nov;85(5):750-5 19896111
Cites Neuropsychopharmacology. 2010 Feb;35(3):834-46 19956089
Cites Mol Psychiatry. 2010 Jun;15(6):589-601 19107115
Cites Isr J Psychiatry Relat Sci. 2010;47(1):72-82 20686202
Cites Am J Psychiatry. 2010 Aug;167(8):949-57 20516156
Cites PLoS Genet. 2010 Aug;6(8). pii: e1001058. doi: 10.1371/journal.pgen.1001058 20714348
Cites Biol Psychiatry. 2010 Sep 15;68(6):578-85 20673876
Cites Biol Psychiatry. 2010 Nov 1;68(9):811-7 20800221
Cites Curr Psychiatry Rep. 2010 Dec;12(6):539-46 20848240
Cites Mol Psychiatry. 2011 Feb;16(2):202-15 20038947
Cites Mol Psychiatry. 2011 Feb;16(2):193-201 20125088
Cites Mol Psychiatry. 2011 Mar;16(3):286-92 20157312
Cites Mol Psychiatry. 2011 May;16(5):516-32 20351714
Cites Neuron. 2011 Apr 28;70(2):252-65 21521612
Cites Am J Hum Genet. 2007 Dec;81(6):1278-83 17966091
Cites Mol Psychiatry. 2011 Jun;16(6):634-46 20386568
Cites Mol Psychiatry. 2011 Jul;16(7):773-83 20567237
Cites Nature. 2011 Jul 7;475(7354):91-5 21677641
Cites Am J Psychiatry. 2011 Aug;168(8):840-7 21572164
Cites Am J Psychiatry. 2011 Aug;168(8):848-52 21572167
Cites Am J Psychiatry. 2011 Aug;168(8):783-9 21813496
Cites Mol Psychiatry. 2012 Jan;17(1):36-48 21042317
Cites Bioinformatics. 2012 Jul 1;28(13):1797-9 22513993
Cites Mol Psychiatry. 2012 Oct;17(10):996-1006 21931320
Cites Int J Neuropsychopharmacol. 2013 Feb;16(1):69-82 22339950
Cites Mol Psychiatry. 2013 Apr;18(4):497-511 22472876
Cites Nat Genet. 2000 May;25(1):25-9 10802651
Cites J Pharmacol Exp Ther. 2001 Oct;299(1):12-20 11561058
Cites Neuropharmacology. 2002 Aug;43(2):251-9 12213279
Cites Brain Res. 2005 Jan 21;1031(2):185-93 15649443
Cites J Neurosci. 2005 Feb 16;25(7):1826-35 15716419
Cites Eur J Neurosci. 2005 Jul;22(2):425-36 16045496
Cites Arch Gen Psychiatry. 2005 Oct;62(10):1097-106 16203955
Cites Neuropsychopharmacology. 2006 Jun;31(6):1112-22 16237391
Cites Mol Psychiatry. 2007 May;12(5):462-73 17179996
Cites Nature. 2007 Oct 18;449(7164):851-61 17943122
GRANTS
GRANTID AGENCY COUNTRY
AA07535 NIAAA NIH HHS United States
AA10248 NIAAA NIH HHS United States
AA13320 NIAAA NIH HHS United States
AA13321 NIAAA NIH HHS United States
AA13326 NIAAA NIH HHS United States
AA14041 NIAAA NIH HHS United States
K05 AA017688 NIAAA NIH HHS United States
K24 MH094614 NIMH NIH HHS United States
MH-079799 NIMH NIH HHS United States
MH-094614 NIMH NIH HHS United States
MH66206 NIMH NIH HHS United States
N01 MH-90003 NIMH NIH HHS United States
NIMH MH086026 PHS HHS United States
R01 MH-072802 NIMH NIH HHS United States
GENERAL NOTE
KEYWORDS
MESH HEADINGS
DESCRIPTORNAME QUALIFIERNAME
Depressive Disorder, Major genetics
Genetic Predisposition to Disease genetics
Genome-Wide Association Study genetics
Glutamic Acid metabolism
Humans metabolism
Synaptic Transmission physiology
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
REGISTRYNUMBER NAMEOFSUBSTANCE
3KX376GY7L Glutamic Acid
OTHER ID's
OTHERID SOURCE
PMC3565768 NLM